Open AccessPalbociclib Combination Prolongs Life After Breast Cancer Hormone Therapy
Author(s) -
Peter M. Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000549787.81947.a8
Subject(s) - fulvestrant , palbociclib , medicine , oncology , breast cancer , interim analysis , cancer , placebo , combination therapy , hazard ratio , gynecology , anastrozole , metastatic breast cancer , randomized controlled trial , tamoxifen , confidence interval , alternative medicine , pathology